products designed to solve your most challenging projects

June 17, 2019

All standard deliveries utilizing the PPG Company delivery service will be free of charge to all serviceable E&I members. Orders placed by noon are delivered the next business day within the standard delivery zone which the local PPG company-operated store network operates and providing goods are in stock. Non-standard orders (large quantities, far distances, etc.) requiring delivery may be placed on a common carrier and the cost associated may be passed on to the customer. Any freight cost (if necessary) will be reviewed and approved with the E&I member prior to shipping.

Spotlight

Cellectis

Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing on its 17 years of expertise in gene editing built on its flagship TALEN® technology and pioneering electroporation system PulseAgile Cellectis uses the power of the immune system to target and eradicate cancer cells. Using its life-science-focused, pioneering genome engineering technologies, Cellectis’ goal is to create innovative products in multiple fields and with various target markets. Cellectis is listed on the Nasdaq market (ticker: CLLS) and on the NYSE Alternext market.

OTHER WHITEPAPERS
news image

AQUAZOL STABILIZED HYDROGEN PEROXIDE

whitePaper | September 11, 2022

Hydrogen peroxide is a reagent used in many industries and this usage is growing especially where it is replacing reagents known or suspected of causing cancer and other long-term health problems.

Read More
news image

Commercial Customs Operations Advisory Committee Next Generation Facilitation Subcommittee 21st Century Customs Framework Task Force Report

whitePaper | January 10, 2023

CBP, and the Partner Government Agencies (PGAs) to share inputs and perspectives on the 21CCF draft legislative concepts.

Read More
news image

Understanding Polymer and Hybrid Capacitors

whitePaper | March 24, 2023

Capacitor may seem simple enough but specifying then has allyactu grown more complex in recent years.

Read More
news image

Specialty Chemicals Manufacturers Can Recoup Investor ROI via Automated Process Flows

whitePaper | November 25, 2022

In specialty chemicals, R&D teams have long struggled to deliver the results investors expect.

Read More
news image

Electrochemical Destruction of Perfluorooctanesulfonatein Electroplating Wastewaters

whitePaper | August 15, 2022

Experiments were conducted to investigate 6:2 FTS oxidation, as this is a common replacement compound for PFOS in the electroplating industry.

Read More
news image

THE ROLE OF AI IN THE CHEMICAL MANUFACTURING INDUSTRY

whitePaper | November 15, 2019

The parts of the world that lack robust chemical manufacturing sectors are nevertheless intimately linked to the chemical industry. They depend mightily on a variety of imported goods provided by chemical producers: plastics, fuel, lubricants, fertilizer, pesticides and much more. Disruptions in the industry, leading to shortages or price hikes, pose a major threat to the economy and wellbeing of many communities throughout the world.

Read More

Spotlight

Cellectis

Cellectis is a clinical-stage biopharmaceutical company focused on developing a new generation of cancer immunotherapies based on gene-edited T-cells (UCART). By capitalizing on its 17 years of expertise in gene editing built on its flagship TALEN® technology and pioneering electroporation system PulseAgile Cellectis uses the power of the immune system to target and eradicate cancer cells. Using its life-science-focused, pioneering genome engineering technologies, Cellectis’ goal is to create innovative products in multiple fields and with various target markets. Cellectis is listed on the Nasdaq market (ticker: CLLS) and on the NYSE Alternext market.

Events